These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33094573)

  • 1. Metabolic Characterization of Anterior Mediastinal Masses by
    Koç ZP; Özcan PP; Ayan E; Bozdoğan Arpacı R
    Mol Imaging Radionucl Ther; 2020 Oct; 29(3):105-111. PubMed ID: 33094573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of thymic masses using (18)F-FDG PET-CT.
    Kumar A; Regmi SK; Dutta R; Kumar R; Gupta SD; Das P; Halanaik D; Jindal T
    Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
    Yudistiro R; Arisaka Y; Tokue A; Nakajima T
    BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors.
    Watanabe T; Shimomura H; Mutoh T; Saito R; Goto R; Yamada T; Notsuda H; Matsuda Y; Noda M; Sakurada A; Taki Y; Okada Y
    Surg Today; 2019 Feb; 49(2):143-149. PubMed ID: 30198048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of maximum standardized uptake value and clinical parameters for improving the accuracy in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
    Yan H; Wang L; Lei B; Ruan M; Chang C; Zhou M; Liu L; Xie W; Wang Y
    Quant Imaging Med Surg; 2024 Feb; 14(2):1944-1956. PubMed ID: 38415117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.
    Yu C; Xia X; Qin C; Sun X; Zhang Y; Lan X
    Contrast Media Mol Imaging; 2018; 2018():3417190. PubMed ID: 30510493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Imaging findings of true thymic hyperplasia at
    Ren J; Fu Z; Zhao Y
    Front Oncol; 2022; 12():1077777. PubMed ID: 36686837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Mediastinal Tumors Using SUV
    Morita T; Tatsumi M; Ishibashi M; Isohashi K; Kato H; Honda O; Shimosegawa E; Tomiyama N; Hatazawa J
    Asia Ocean J Nucl Med Biol; 2017; 5(1):22-29. PubMed ID: 28840135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 11C-choline positron emission tomography-computed tomography and videomediastinoscopy in the evaluation of diseases of middle mediastinum.
    Liu Q; Peng ZM; Liu QW; Yao SZ; Zhang L; Meng L; Chen JH
    Chin Med J (Engl); 2006 Apr; 119(8):634-9. PubMed ID: 16635407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
    Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
    Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Role of MDCT and FDG-PET/CT in the Diagnostic Evaluation of Mediastinal Mass Lesions: An Institutional Experience.
    Reddy R
    World J Nucl Med; 2022 Sep; 21(3):200-209. PubMed ID: 36060087
    [No Abstract]   [Full Text] [Related]  

  • 18. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
    Proli C; De Sousa P; Jordan S; Anikin V; Devaraj A; Love SM; Shackcloth M; Kostoulas N; Papagiannopoulos K; Haqzad Y; Loubani M; Sellitri F; Granato F; Bush A; Marchbank A; Iyer S; Scarci M; Lim E;
    BMJ Open; 2018 Feb; 8(2):e019471. PubMed ID: 29437755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
    Pahk K; Chung JH; Yi E; Kim S; Lee SH
    Eur J Radiol; 2018 Sep; 106():145-149. PubMed ID: 30150037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.